Tech Company M&A Transactions
Paragon Bioservices Acquisition
On 4/16/2019, Paragon Bioservices was bought by Catalent. The acquisition price was $1.2 billion.
Transaction Overview
Company Name
Acquired By
Announced On
4/16/2019
Transaction Type
M&A
Amount
$1,200,000,000
M&A Terms
The definitive merger agreement for the acquisition contemplates an all-cash purchase of all of Paragon's outstanding equity for $1.2 billion on a cash-free, debt-free basis.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
801 W. Baltimore St. 302
Baltimore, MD 21201
USA
Baltimore, MD 21201
USA
Phone
Website
Email Address
Not Recorded
Overview
Highly-flexible and responsive, we work in partnership with our clients to ensure efficient and cost-effective preclinical target validation services, process development and scale-up production of biopharmaceuticals for research purposes or Phase I/II clinical trials.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Buzy
Chief Financial Officer
Gerard Fleury
Chief Information Officer
Dermot McCaul
Chief Scientific Officer
William Thomas
Vice President
George Buchman
VP - Bus. Development
Philip Wills
VP - Finance
Anne Shiflett
VP - Human Resources
Ruby Hofmann
VP - Manufacturing
John Conner
VP - Manufacturing
Randy Henrickson
VP - Regulatory Affairs
Deborah Wild
Browse more venture capital transactions:
Prev: 4/16/2019: EIP Pharma venture capital transaction
Next: 4/16/2019: Path Network venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on all VC transactions involving tech companies. VC transactions on this site are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs